Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Hormone replacement therapy and the risk of breast cancer: How much should women worry about it?

Climént-Palmer M, Spiegelhalter D.

Post Reprod Health. 2019 Dec;25(4):175-178. doi: 10.1177/2053369119898586. No abstract available.

PMID:
31941376
2.

Communicating uncertainty about facts, numbers and science.

van der Bles AM, van der Linden S, Freeman ALJ, Mitchell J, Galvao AB, Zaval L, Spiegelhalter DJ.

R Soc Open Sci. 2019 May 8;6(5):181870. doi: 10.1098/rsos.181870. eCollection 2019 May. Review.

3.

Communicating health risks in science publications: time for everyone to take responsibility.

Freeman ALJ, Spiegelhalter DJ.

BMC Med. 2018 Nov 13;16(1):207. doi: 10.1186/s12916-018-1194-4.

4.

Winners and Losers: Communicating the Potential Impacts of Policies: Commentary on Zeller.

Brick C, Spiegelhalter DJ.

Nicotine Tob Res. 2019 Feb 18;21(3):336-337. doi: 10.1093/ntr/nty197. No abstract available.

PMID:
30312453
5.

Commentary on Piumatti et al. 2018.

Spiegelhalter D.

J Public Health (Oxf). 2018 Jun 1;40(2):312. doi: 10.1093/pubmed/fdy038. No abstract available.

PMID:
29506039
6.

Improving risk adjustment in the PRAiS (Partial Risk Adjustment in Surgery) model for mortality after paediatric cardiac surgery and improving public understanding of its use in monitoring outcomes.

Pagel C, Rogers L, Brown K, Ambler G, Anderson D, Barron D, Blackshaw E, Crowe S, English K, Franklin R, Jesper E, Meagher L, Pearson M, Rakow T, Salamonowicz M, Spiegelhalter D, Stickley J, Thomas J, Tibby S, Tsang V, Utley M, Witter T.

Southampton (UK): NIHR Journals Library; 2017 Jul.

7.

Communicating risk in primary care: what the Academy of Medical Sciences' report means in practice.

Freeman A, Marshall M, Treadwell J, Spiegelhalter D, Rafi I.

Br J Gen Pract. 2017 Aug;67(661):346-347. doi: 10.3399/bjgp17X691793. No abstract available.

8.

Understanding Children's Heart Surgery Data: A Cross-Disciplinary Approach to Codevelop a Website.

Pagel C, Jesper E, Thomas J, Blackshaw E, Rakow T, Pearson M, Spiegelhalter D.

Ann Thorac Surg. 2017 Jul;104(1):342-352. doi: 10.1016/j.athoracsur.2016.11.080. Epub 2017 Mar 15. Review.

9.

Cancer Drugs Fund requires further reform.

Grieve R, Abrams K, Claxton K, Goldacre B, James N, Nicholl J, Parmar M, Parker C, Sekhon JS, Smeeth L, Spiegelhalter D, Sculpher M.

BMJ. 2016 Sep 27;354:i5090. doi: 10.1136/bmj.i5090. No abstract available.

10.

Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data.

Rhodes KM, Turner RM, White IR, Jackson D, Spiegelhalter DJ, Higgins JP.

Stat Med. 2016 Dec 20;35(29):5495-5511. doi: 10.1002/sim.7090. Epub 2016 Aug 30.

11.

How old are you, really? Communicating chronic risk through 'effective age' of your body and organs.

Spiegelhalter D.

BMC Med Inform Decis Mak. 2016 Aug 5;16:104. doi: 10.1186/s12911-016-0342-z.

12.

Patient reactions to a web-based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care.

Nolan T, Dack C, Pal K, Ross J, Stevenson FA, Peacock R, Pearson M, Spiegelhalter D, Sweeting M, Murray E.

Br J Gen Pract. 2015 Mar;65(632):e152-60. doi: 10.3399/bjgp15X683953.

13.

Making sense of uncertainty, risk and chance in public health.

Spiegelhalter D.

Vet Rec. 2015 Jan 17;176(3):65. doi: 10.1136/vr.g7591. No abstract available.

PMID:
25598464
14.

Robust meta-analytic-predictive priors in clinical trials with historical control information.

Schmidli H, Gsteiger S, Roychoudhury S, O'Hagan A, Spiegelhalter D, Neuenschwander B.

Biometrics. 2014 Dec;70(4):1023-32. doi: 10.1111/biom.12242. Epub 2014 Oct 29.

PMID:
25355546
15.

The pros and cons of funnel plots as an aid to risk communication and patient decision making.

Rakow T, Wright RJ, Spiegelhalter DJ, Bull C.

Br J Psychol. 2015 May;106(2):327-48. doi: 10.1111/bjop.12081. Epub 2014 Aug 14.

PMID:
25123852
16.

Statistics. The future lies in uncertainty.

Spiegelhalter DJ.

Science. 2014 Jul 18;345(6194):264-5. doi: 10.1126/science.1251122. Epub 2014 Jul 17. No abstract available.

PMID:
25035471
17.

The power of the MicroMort.

Spiegelhalter DJ.

BJOG. 2014 May;121(6):662-3. doi: 10.1111/1471-0528.12663. No abstract available.

18.

Information visualisation for science and policy: engaging users and avoiding bias.

McInerny GJ, Chen M, Freeman R, Gavaghan D, Meyer M, Rowland F, Spiegelhalter DJ, Stefaner M, Tessarolo G, Hortal J.

Trends Ecol Evol. 2014 Mar;29(3):148-57. doi: 10.1016/j.tree.2014.01.003. Epub 2014 Feb 21.

PMID:
24565371
19.

Policy: Twenty tips for interpreting scientific claims.

Sutherland WJ, Spiegelhalter D, Burgman MA.

Nature. 2013 Nov 21;503(7476):335-7. No abstract available.

PMID:
24273799
20.

Are you 45% more likely to die in a UK hospital rather than a US hospital?

Spiegelhalter D.

BMJ. 2013 Sep 24;347:f5775. doi: 10.1136/bmj.f5775. No abstract available.

PMID:
24065613
21.

Statistics behind the headlines. Have there been 13,000 needless deaths at 14 NHS trusts?

Spiegelhalter D.

BMJ. 2013 Aug 7;347:f4893. doi: 10.1136/bmj.f4893. No abstract available.

PMID:
23924510
22.

Use of implicit and explicit bayesian methods in health technology assessment.

Cooper NJ, Spiegelhalter D, Bujkiewicz S, Dequen P, Sutton AJ.

Int J Technol Assess Health Care. 2013 Jul;29(3):336-42. doi: 10.1017/S0266462313000354. Review.

PMID:
23863191
23.

Bicycle helmets and the law.

Goldacre B, Spiegelhalter D.

BMJ. 2013 Jun 12;346:f3817. doi: 10.1136/bmj.f3817. No abstract available.

24.

Transparent interactive decision interrogator-reply to letter to the editor by Michael Coory.

Bujkiewicz S, Sutton AJ, Abrams KR, Cooper NJ, Spiegelhalter DJ.

Value Health. 2013 Jan-Feb;16(1):216-7. doi: 10.1016/j.jval.2012.10.014. No abstract available.

25.

Impact of plain packaging of tobacco products on smoking in adults and children: an elicitation of international experts' estimates.

Pechey R, Spiegelhalter D, Marteau TM.

BMC Public Health. 2013 Jan 9;13:18. doi: 10.1186/1471-2458-13-18.

26.

Using speed of ageing and "microlives" to communicate the effects of lifetime habits and environment.

Spiegelhalter D.

BMJ. 2012 Dec 14;345:e8223. doi: 10.1136/bmj.e8223. No abstract available.

PMID:
23247978
27.

Simple and multistate survival curves: can people learn to use them?

Rakow T, Wright RJ, Bull C, Spiegelhalter DJ.

Med Decis Making. 2012 Nov-Dec;32(6):792-804. doi: 10.1177/0272989X12451057. Epub 2012 Jun 29.

PMID:
22753419
28.

A collaboratively-derived science-policy research agenda.

Sutherland WJ, Bellingan L, Bellingham JR, Blackstock JJ, Bloomfield RM, Bravo M, Cadman VM, Cleevely DD, Clements A, Cohen AS, Cope DR, Daemmrich AA, Devecchi C, Anadon LD, Denegri S, Doubleday R, Dusic NR, Evans RJ, Feng WY, Godfray HC, Harris P, Hartley SE, Hester AJ, Holmes J, Hughes A, Hulme M, Irwin C, Jennings RC, Kass GS, Littlejohns P, Marteau TM, McKee G, Millstone EP, Nuttall WJ, Owens S, Parker MM, Pearson S, Petts J, Ploszek R, Pullin AS, Reid G, Richards KS, Robinson JG, Shaxson L, Sierra L, Smith BG, Spiegelhalter DJ, Stilgoe J, Stirling A, Tyler CP, Winickoff DE, Zimmern RL.

PLoS One. 2012;7(3):e31824. doi: 10.1371/journal.pone.0031824. Epub 2012 Mar 9.

29.

Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Turner RM, Lloyd-Jones M, Anumba DO, Smith GC, Spiegelhalter DJ, Squires H, Stevens JW, Sweeting MJ, Urbaniak SJ, Webster R, Thompson SG.

PLoS One. 2012;7(2):e30711. doi: 10.1371/journal.pone.0030711. Epub 2012 Feb 3.

30.

Don't know, can't know: embracing deeper uncertainties when analysing risks.

Spiegelhalter DJ, Riesch H.

Philos Trans A Math Phys Eng Sci. 2011 Dec 13;369(1956):4730-50. doi: 10.1098/rsta.2011.0163.

PMID:
22042895
31.

Visualizing uncertainty about the future.

Spiegelhalter D, Pearson M, Short I.

Science. 2011 Sep 9;333(6048):1393-400. doi: 10.1126/science.1191181. Review.

PMID:
21903802
32.

Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care.

Bujkiewicz S, Jones HE, Lai MC, Cooper NJ, Hawkins N, Squires H, Abrams KR, Spiegelhalter DJ, Sutton AJ.

Value Health. 2011 Jul-Aug;14(5):768-76. doi: 10.1016/j.jval.2010.12.002. Epub 2011 Apr 30.

33.

Modelling bias in combining small area prevalence estimates from multiple surveys.

Manzi G, Spiegelhalter DJ, Turner RM, Flowers J, Thompson SG.

J R Stat Soc Ser A Stat Soc. 2011 Jan;174(1):31-50.

34.

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N.

Health Technol Assess. 2011 Feb;15(10):i-xxi, 1-329. doi: 10.3310/hta15100. Review.

35.

How valuable are multiple treatment comparison methods in evidence-based health-care evaluation?

Cooper NJ, Peters J, Lai MC, Juni P, Wandel S, Palmer S, Paulden M, Conti S, Welton NJ, Abrams KR, Bujkiewicz S, Spiegelhalter D, Sutton AJ.

Value Health. 2011 Mar-Apr;14(2):371-80. doi: 10.1016/j.jval.2010.09.001. Epub 2011 Feb 5.

36.

Summarizing historical information on controls in clinical trials.

Neuenschwander B, Capkun-Niggli G, Branson M, Spiegelhalter DJ.

Clin Trials. 2010 Feb;7(1):5-18. doi: 10.1177/1740774509356002.

PMID:
20156954
37.

Rejoinder to commentaries on 'The BUGS project: Evolution, critique and future directions'.

Lunn D, Spiegelhalter D, Thomas A, Best N.

Stat Med. 2009 Nov 10;28(25):3081-2. doi: 10.1002/sim.3691. No abstract available.

PMID:
19827062
38.

A note on the power prior.

Neuenschwander B, Branson M, Spiegelhalter DJ.

Stat Med. 2009 Dec 10;28(28):3562-6. doi: 10.1002/sim.3722.

PMID:
19735071
39.

The BUGS project: Evolution, critique and future directions.

Lunn D, Spiegelhalter D, Thomas A, Best N.

Stat Med. 2009 Nov 10;28(25):3049-67. doi: 10.1002/sim.3680.

PMID:
19630097
40.

Using routine intelligence to target inspection of healthcare providers in England.

Bardsley M, Spiegelhalter DJ, Blunt I, Chitnis X, Roberts A, Bharania S.

Qual Saf Health Care. 2009 Jun;18(3):189-94. doi: 10.1136/qshc.2007.024802.

PMID:
19468000
41.

A re-evaluation of random-effects meta-analysis.

Higgins JP, Thompson SG, Spiegelhalter DJ.

J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137-159.

42.

Bias modelling in evidence synthesis.

Turner RM, Spiegelhalter DJ, Smith GC, Thompson SG.

J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):21-47.

43.

Accounting for regression-to-the-mean in tests for recent changes in institutional performance: analysis and power.

Jones HE, Spiegelhalter DJ.

Stat Med. 2009 May 30;28(12):1645-67. doi: 10.1002/sim.3583.

PMID:
19358144
44.

Combining MCMC with 'sequential' PKPD modelling.

Lunn D, Best N, Spiegelhalter D, Graham G, Neuenschwander B.

J Pharmacokinet Pharmacodyn. 2009 Feb;36(1):19-38. doi: 10.1007/s10928-008-9109-1. Epub 2009 Jan 9.

PMID:
19132515
45.

Fairness of financial penalties to improve control of Clostridium difficile.

Walker AS, Spiegelhalter D, Crook DW, Wyllie D, Morris J, Peto TE.

BMJ. 2008 Nov 20;337:a2097. doi: 10.1136/bmj.a2097. No abstract available.

PMID:
19022838
46.

How to interpret your dot: decoding the message of clinical performance indicators.

Schulman J, Spiegelhalter DJ, Parry G.

J Perinatol. 2008 Sep;28(9):588-96. doi: 10.1038/jp.2008.67. Epub 2008 Jul 17.

PMID:
18633418
47.

Understanding uncertainty.

Spiegelhalter DJ.

Ann Fam Med. 2008 May-Jun;6(3):196-7. doi: 10.1370/afm.848. No abstract available. Erratum in: Ann Fam Med. 2008 Jul-Aug;6(4):372.

48.

Use of the false discovery rate when comparing multiple health care providers.

Jones HE, Ohlssen DI, Spiegelhalter DJ.

J Clin Epidemiol. 2008 Mar;61(3):232-240. doi: 10.1016/j.jclinepi.2007.04.017. Epub 2007 Oct 23.

PMID:
18226745
49.

Allowing for correlations between correlations in random-effects meta-analysis of correlation matrices.

Prevost AT, Mason D, Griffin S, Kinmonth AL, Sutton S, Spiegelhalter D.

Psychol Methods. 2007 Dec;12(4):434-450. doi: 10.1037/1082-989X.12.4.434.

PMID:
18179354
50.

Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial.

Kinmonth AL, Wareham NJ, Hardeman W, Sutton S, Prevost AT, Fanshawe T, Williams KM, Ekelund U, Spiegelhalter D, Griffin SJ.

Lancet. 2008 Jan 5;371(9606):41-8. doi: 10.1016/S0140-6736(08)60070-7.

PMID:
18177774

Supplemental Content

Loading ...
Support Center